Aurinia Pharmaceuticals Inc(NASDAQ:AUPH) 
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agree...
Website: http://www.auriniapharma.com
Founded: 2012
Full Time Employees: 62
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 7.81
H 7.98
L 7.72
C 7.81
V 1,567,420
10EMA 7.81
20EMA 7.81
60EMA 7.81
120EMA 7.81
250EMA 7.81